It was first started by Eli Lilly nearly 70 years ago and split off into its own publicly traded company in 2019. An artist’s rendering of the new Elanco corporate headquarters near downtown ...

The vote clears the way for a proposed multibillion-dollar expansion of the former Nexus Pharmaceuticals facility.

Eli Lilly and Co. is in negotiations with several states and plans to announce the locations of four new manufacturing plants later this year.

INDIANAPOLIS — Eli Lilly announced Wednesday the launch of higher doses of Zepbound — and that the company is lowering the price of certain doses. People taking Zepbound, or interested in starting, ...

INDIANAPOLIS - Eli Lilly and Company (NYSE:LLY), the global pharmaceutical giant, has announced a second-quarter dividend of $1.30... Eli Lilly & Co. (NYSE:LLY) declared a quarterly dividend ...

INDIANAPOLIS — Eli Lilly and Company is announcing a massive new set of investments in U.S. manufacturing. The company plans to more than double its investments since 2020, bringing the total to more ...

INDIANAPOLIS - Eli Lilly and Company (NYSE: NYSE:LLY) announced today that Anat Ashkenazi has resigned from her position as Chief... Alphabet (NASDAQ:GOOGL) has appointed Anat Ashkenazi as its new ...

Eli Lilly and Co. Wednesday announced ... 13,000 manufacturing and construction jobs. Lilly will invest $27 billion in the four plants, the Indianapolis drugmaker announced at a press conference ...

Eli Lilly said Wednesday it will invest $27 billion ... the threat of drug import duties from the Trump administration. The Indianapolis-based company said three of the planned facilities will ...

Eli Lilly, based in Indianapolis, says it is in negotiations with several states about the expansions. Economic development officials in North Carolina declined to say whether the state is in ...

The Indianapolis-based company has announced that it is selling higher doses of Zepbound in single-dose vials at as much as half its usual list price, depending on the dosage. Eli Lilly says it is ...